.-
.- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
http://lm360.us/Rositano-mother-of-Huckins-from-Rfol-De-Salem?Bazzlebro=286
.-
.
scottish widows has its eyes on the master trust prize .
![](#dana-rohrabacher-gty-hb-180516_hpmain_16x9t_240.jpg)